Frontal sinus obliteration is a procedure usually reserved for select cases of refractory chronic rhinosinusitis, tumors and trauma management. These conditions are relatively rare in children, which makes the procedure even rarer in the pediatric population. Bioactive glass S53P4 is a biocompatible mineral allogenic material used in various applications in maxillofacial, orthopedic and head and neck surgery. Although its’ osteo-stimulating and antibacterial properties, as well as clinical outcomes are well documented in literature, limited data exists about its’ use in frontal sinus obliteration in children is scarce. We present two cases of successful frontal sinus obliteration with S53P4 in different clinical indications, where an inflammatory process and an osteoma have produced bone destruction between the frontal sinus, the orbit and the anterior crania fossa. Bioactive glass in both cases has proven to be easy to use and effective in achieving frontal sinus obliteration in a pediatric patient.
Background/Objectives: Facial nerve paresis (FNP) is a well-known infratemporal complication of acute otitis media (AOM). The objective of this study was to characterize pediatric patients affected by FNP secondary to AOM under different management protocols, to assess short-term outcomes, and to identify factors requiring extensive surgical intervention in our cohort. Methods: A retrospective, observational, and descriptive analysis of patients hospitalized at the department between 2020–2025 due to FNP in the course of AOM was performed. Data were collected and analyzed using Microsoft Excel and a publicly available online calculator. Results: A total of 29 patients matching the inclusion criteria were identified, with mean age of 8.0 years. Upon admission, the House–Brackmann (HB) grade was mostly III or higher, whereas most patients were discharged with a grade of II or lower, indicating favorable short-term outcomes. All patients received antibiotic treatment, with the majority receiving concomitant steroid treatment (93.1%) and surgical intervention. An HB grade of IV on admission and a duration of symptoms exceeding two weeks were nominally significant factors associated with mastoidectomy in our cohort (p = 0.01 for both variables). No nominally significant differences were found between the mastoidectomy and non-mastoidectomy groups regarding inflammatory marker levels, ear discharge on admission, or a history of AOM within the month prior to hospitalization. Conclusions: FNP secondary to AOM in children carries a favorable prognosis. However, standardized treatment guidelines in this entity are still lacking, and most centers rely on institutional experience. Multicenter studies are warranted to standardize management protocols.
Waterbirth has become a widely adopted alternative to a conventional delivery, with well-documented maternal benefits, but there is an ongoing debate regarding neonatal safety. We would like to report a case of a 10-day-old male neonate who developed acute otitis externa (AOE) following waterbirth. Despite the rare occurrence of this disease in children under 2 years of age, prompt diagnosis and timely initiation of appropriate therapy led to a full recovery. This case represents a previously undocumented, yet plausible, complication of waterbirth and underscores the importance of careful neonatal ear assessment and preventive measures in aquatic deliveries.